Hillion J, Le Coniat M, Jonveaux P, Berger R, Bernard O A
Unité Institut National de la Santé et de la Recherche Médicale (INSERM) U301 and Structure d' Intervention (SD) 401 No. 301 Centre National de la Recherche Scientifique (CNRS), Institut de Génétique Moléculaire, Paris, France.
Blood. 1997 Nov 1;90(9):3714-9.
Fusion genes implicating the MLL gene have been recently demonstrated in various 11q23 chromosomal abnormalities in human hematopoietic malignancies. We analyzed a t(6;11)(q21;q23) translocation detected in a secondary acute myeloblastic leukemia. This translocation results in fusion of the MLL gene on 11q23 to a previously unknown gene on chromosome 6 that differs from the previously reported MLL partner gene AF6q. The novel gene, named AF6q21, encodes a forkhead (FH) protein with strong similarities to the two FH family members whose genes are already known to be involved in chromosomal translocations of human malignancies, AFX and FKHR. Strikingly, in these translocations the breakpoints are located at the same position within the FH domains. Therefore, AF6q21, AFX, and FKHR could define a new FH subfamily particularly involved in human malignancies.
最近在人类造血系统恶性肿瘤的各种11q23染色体异常中证实了涉及MLL基因的融合基因。我们分析了在一例继发性急性髓细胞白血病中检测到的t(6;11)(q21;q23)易位。这种易位导致11q23上的MLL基因与6号染色体上一个先前未知的基因融合,该基因不同于先前报道的MLL伙伴基因AF6q。这个新基因名为AF6q21,编码一种叉头(FH)蛋白,与两个FH家族成员有很强的相似性,已知这两个家族成员的基因参与人类恶性肿瘤的染色体易位,即AFX和FKHR。引人注目的是,在这些易位中,断点位于FH结构域内的相同位置。因此,AF6q21、AFX和FKHR可能定义了一个特别涉及人类恶性肿瘤的新的FH亚家族。